Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation.

European journal of haematology - 1 Jan 2016

Peng Jie, Zuo Zhuang, Fu Bin, Oki Yasuhiro, Tang Guilin, Goswami Maitrayee, Priyanka Priyanka, Muzzafar Tariq, Medeiros L Jeffrey, Luthra Rajyalakshmi, Wang Sa A

Abstract excerpt

Nucleophosmin (NPM1) mutations in chronic myelomonocytic leukemia (CMML) are extremely uncommon, and the clinicopathologic features of these neoplasms are poorly characterized. Over a 10-yr interval, NPM1 mutation analysis was performed in 152 CMML at our institution. NPM1 mutations were identified in 8 (5.3%) patients, five men and three women, with a median age of 72 yr (range, 27-87). In all patients, the bone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ASXL1 gene

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Mutation

Share to Neoplasm Proteins

Share to Nuclear Proteins

Share to Nucleophosmin

Source

Identifiers

PMID: 25809997
DOI: 10.1111/ejh.12549

Genes

NPM1
ASXL1
FLT3
KRAS
NRAS
TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation.PMID 25809997Read ↗

Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevanceSemantic proximity Read ↗

Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.Semantic proximity Read ↗

Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?Semantic proximity Read ↗

Nucleophosmin gene mutations in acute myeloid leukemia.Semantic proximity Read ↗

Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field.Semantic proximity Read ↗

Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.Semantic proximity Read ↗

NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapySemantic proximity Read ↗

Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin (NPM1) gene mutation subtypes: a single-center experience and review of the literature.Semantic proximity Read ↗

NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemiaSemantic proximity Read ↗

Biology and Management of Acute Myeloid Leukemia With Mutated NPM1.Semantic proximity Read ↗

NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?Semantic proximity Read ↗

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.